Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Leap Therapeutics Inc LPTX

Healthcare Biotechnology
Leap Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways. The Company’s lead clinical stage drug candidate is sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1 (DKK1). DKK1 is also a modulator... see more

Current News (NDAQ:LPTX)

Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025

PR Newswire October 20, 2025

Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy

PR Newswire October 9, 2025

Leap Therapeutics Announces $58.88 Million Private Placement in Cash Commitments Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy

PR Newswire October 6, 2025

Leap Therapeutics to Present Final Clinical Data from Part B of the DeFianCe Study at the ESMO Congress 2025

PR Newswire September 25, 2025

Leap Therapeutics Reports Second Quarter 2025 Financial Results

PR Newswire August 14, 2025

Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives

PR Newswire June 23, 2025

Leap Therapeutics Reports First Quarter 2025 Financial Results

PR Newswire May 13, 2025

Leap Therapeutics to Present Preclinical Data of FL-501, a Novel GDF-15 Neutralizing Antibody, at the AACR 2025 Annual Meeting

PR Newswire April 25, 2025

Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer

PR Newswire April 15, 2025
View More News ››

Opinion & Analysis (NDAQ:LPTX)

Leap Therapeutics Lunges Forward on $132M Licensing Deal and $27M Equity Raise

Streetwise Reports January 6, 2020
View More Opinion ››

Bullboard Posts (NDAQ:LPTX)

4 SMALL-CAP BIOTECH STOCKS FOR YOUR INVESTMENT PORTFOLIO!

$LPTX $VYGR $OCUL $MNMD   Clinical-Stage companies offer an exciting investment opportunity with massive upside potential....
AviseAnalytics - November 1, 2021

still holding this stock

breaking out to the upside,so glta shareholders.
coolfooldumbguy - February 19, 2020

still holding this stock

from last spring and it looks like an upswing is in progress after all this time,so glta shareholders.
coolfooldumbguy - January 23, 2020

In

@ 1.90
puffdragon699 - March 28, 2019

it's a buy today for me

this morning,it should do well in the biotech work it is doing,so glta.
coolfooldumbguy - March 18, 2019
View more Bullboard ››

Blue Sky Uranium Corp.

Blue Sky Uranium Corp.

Blue Sky Uranium Corp. is a uranium and vanadium exploration company. The Company controls more than 480,000 hectares(ha ...
View More »